Magnera (MAGN) vs Nu Skin Enterprises (NUS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Magnera (MAGN) has outperformed Nu Skin Enterprises (NUS) over the past year, gaining 5.9% versus a loss of 57.6%. Over five years, NUS leads with a -88.4% price change compared with -94.4% for MAGN. Magnera is the larger company by market cap ($417.7 million vs $232.2 million), about 1.8 times the size.
On valuation, Nu Skin Enterprises trades at a lower forward P/E (4.1x vs 7.2x for Magnera). Nu Skin Enterprises pays a dividend yielding 5.03%, while Magnera does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MAGN | NUS |
|---|---|---|
| Share price | $11.65 | $4.77 |
| Market cap | $417.65M | $232.19M |
| 1-day change | -0.09% | -0.63% |
| YTD return | -23.05% | -50.42% |
| 1-year return | +5.91% | -57.64% |
| 5-year return | -94.42% | -88.38% |
| Forward P/E | 7.15 | 4.11 |
| EPS (TTM) | $-3.13 | $-4.51 |
| Dividend yield | 0.00% | 5.03% |
| Annual dividend | $0.00 | $0.24 |
| 52-week high | $15.52 | $11.67 |
| 52-week low | $7.82 | $4.45 |
| Distance from 52-week high | -24.94% | -59.13% |
| Analyst consensus | none | none |
| Avg. price target upside | +33.05% | +167.71% |
| Average volume | 425.04K | 557.63K |
| Shares outstanding | 35.85M | 48.68M |
| Employees | 8,000 | 2,800 |
| Sector | Basic Materials | Health Care |
| Industry | Paper | Other Pharmaceuticals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MAGN has outperformed NUS by 63.5 percentage points over the past year.
- Nu Skin Enterprises offers a meaningfully higher dividend yield (5.03% vs 0.00%).
- The two companies sit in different sectors: Magnera in Basic Materials and Nu Skin Enterprises in Health Care.
About Magnera
MAGN stock →Magnera Corporation manufactures and sells non-woven and related products worldwide. It sells its products primarily into consumer-oriented end markets, such as healthcare, and personal care.
Basic Materials · Paper · 8,000 employees
About Nu Skin Enterprises
NUS stock →Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands.
Health Care · Other Pharmaceuticals · 2,800 employees
MAGN vs NUS FAQ
Which is bigger, Magnera or Nu Skin Enterprises?
Magnera (MAGN) is larger, with a market capitalization of $417.65M compared with $232.19M for Nu Skin Enterprises (NUS).
Which stock has performed better over the past year, MAGN or NUS?
MAGN returned +5.91% over the past 12 months, compared with -57.64% for NUS (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Magnera or Nu Skin Enterprises?
Nu Skin Enterprises pays a dividend yielding 5.03%, while Magnera does not currently pay a regular dividend.
Are Magnera and Nu Skin Enterprises in the same industry?
No. Magnera is in the Basic Materials sector, while Nu Skin Enterprises is in Health Care.